Approaches to Cancer Prevention Based on an Understanding of N-Nitrosamine Carcinogenesis
The DOI matches its Crossref record.
Abstract
Understanding carcinogenesis is critical for development of rational approaches to cancer prevention. This paper uses N-nitrosamine carcinogenesis as an example. N-Nitrosamines are a large group of potent carcinogens. Approximately 300 different N-nitrosamines are carcinogenic. At least 30 animal species are responsive to their effects. There is little doubt that humans exposed to sufficient amounts of N-nitrosamines would also be susceptible to their carcinogenic effects. Human exposure to preformed N-nitrosamines occurs through the diet, in certain occupational settings, and through the use of tobacco products, cosmetics, pharmaceutical products, and agricultural chemicals. Diminishing human exposure to these carcinogens is one approach to prevention of cancer, and this has been accomplished in many instances, although exposure to N-nitrosamines in tobacco products is still unacceptably high. Human exposure to N-nitrosamines also occurs by nitrosation of amines in the body, via their acid or bacterial catalyzed reaction with nitrite, or by reaction with products of nitric oxide generated during inflammation or infection. A second approach toward prevention of N-nitrosamine carcinogenesis is inhibition of this endogenous N-nitrosamine formation. Substantial reductions have been achieved with ascorbic acid and other nitrite scavengers. N-Nitrosamines undergo a simple cytochrome P450-mediated metabolic activation step, which is critical for their carcinogenicity. The third approach involves the use of chemopreventive agents that block this step, or other steps in the carcinogenic process. A large number of potent chemopreventive agents against nitrosamine carcinogenesis have been identified. Chemoprevention of lung cancer induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is discussed as an example of this approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lung Cancer: Epidemiology, Etiology, and Prevention
Dela Cruz, C. S., Tanoue, L. T., & Matthay, R. A. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.09.001 · Cited by 2,484
Bade, B. C., & Dela Cruz, C. S. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.10.001 · Cited by 1,911
Carr, A. C., & Frei, B. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1086 · Cited by 940
The molecular biology of cancer
Bertram, J. S. (2000) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00007-8 · Cited by 585
Detection of Lung Cancer With Volatile Markers in the Breatha
Phillips, M., Cataneo, R. N., Cummin, A. R. C., Gagliardi, A. J., Gleeson, K., Greenberg, J., Maxfield, R. A., & Rom, W. N. (2003) · Chest · doi:10.1378/chest.123.6.2115 · Cited by 567
Metabolic Diversity of the Intestinal Microbiota: Implications for Health and Disease1,
Blaut, M., & Clavel, T. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.751s · Cited by 420
Benigni, R., & Bossa, C. (2011) · Chemical Reviews · doi:10.1021/cr100222q · Cited by 377
Ingested nitrate and nitrite and stomach cancer risk: An updated review
Bryan, N. S., Alexander, D. D., Coughlin, J. R., Milkowski, A. L., & Boffetta, P. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.07.062 · Cited by 335
Biology of nitric oxide signaling
Liaudet, L., Soriano, F. G., & Szabó, C. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004001-00005 · Cited by 326
Bain, M. A., Faull, R., Fornasini, G., Milne, R. W., & Evans, A. M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk056 · Cited by 282
“N -nitrosodimethylamine does not elicit its carcinogenic effects directly, but requires metabolic activation in the liver, particularly by the cytochrome P450 2E1 isoenzyme, to form highly reactive alkylating intermediates that have the ability to methylate target organ DNA [18].”
BackgroundResultInfluentialNitrite and Nitrate Analyses: A Clinical Biochemistry Perspective
Ellis, G., Adatia, I., Yazdanpanah, M., & Makela, S. K. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00015-0 · Cited by 264
Song, J., Kwon, O., Chen, S., Daruwala, R., Eck, P., Park, J. B., & Levine, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110496200 · Cited by 257
Inflammation-Induced Cell Proliferation Potentiates DNA Damage-Induced Mutations In Vivo
Kiraly, O., Gong, G., Olipitz, W., Muthupalani, S., & Engelward, B. P. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1004901 · Cited by 169
Is nitric oxide overproduction the target of choice for the management of septic shock?
Feihl, F., Waeber, B., & Liaudet, L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00155-3 · Cited by 151
The complex metabolism of trimethylamine in humans: endogenous and exogenous sources
Chhibber-Goel, J., Gaur, A., Singhal, V., Parakh, N., Bhargava, B., & Sharma, A. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2016.6 · Cited by 93
Nitrate Exposure and Endogenous Formation of Carcinogenic Nitrosamines in Humans
Vermeer, I. T. M., & van Maanen, J. M. S. (2001) · Reviews on Environmental Health · doi:10.1515/reveh.2001.16.2.105 · Cited by 38
Kitamura, Y., Yamagishi, M., Okazaki, K., Furukawa, F., Imazawa, T., Nishikawa, A., & Hirose, M. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.04.004 · Cited by 4
Metadata
- Authors
- Hecht, S. S.
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 1997-11-01
- Volume
- 216
- Issue
- 2
- Pages
- 181-191
- ISSN
- 0071-3384 (ISSN-L)
- 1535-3702
- 1535-3699
- OpenAlex
- W2106982482
- Cited by
- 198
- References
- 0
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.